A new study has found that high-dose vitamin B3, also known as niacin, may offer benefits for patients with glioblastoma, an aggressive form of brain cancer.

The research examined the effects of high-dose niacin therapy on patients diagnosed with glioblastoma, which is considered one of the most challenging brain cancers to treat due to its rapid progression and resistance to conventional therapies.

According to the study results, 82 percent of trial participants showed no disease progression after six months of treatment. The therapy appears to work by boosting immune system function, potentially helping the body better fight the cancer.

Glioblastoma typically carries a poor prognosis, with most patients surviving less than two years after diagnosis. The cancer affects both adults and children, though it is more common in older adults.

The findings suggest that vitamin B3 supplementation at high doses may represent a new approach to managing this aggressive cancer, though researchers note that further studies would be needed to confirm the therapy's effectiveness and establish optimal treatment protocols.